Completed NA INTERVENTIONAL 2-arm NCT00797693

Misoprostol in Termination of First Trimester Missed Abortion

Oral Versus Vaginal Misoprostol as Cervical Ripening Agent Prior to Surgical Termination of First Trimester Missed Abortions in Hawler Maternity Teaching Hospital in Erbil/Iraq

Sponsor: HAWLER Maternity Hospital

Conditions Miscarriage

Interventions Misoprostol ( Cytotec) 200 microgram a tablet

Updated 5 times since 2017 Last updated: Nov 24, 2008 Started: Jan 31, 2008 Primary completion: May 31, 2008 Completion: May 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00797693, this NA trial focuses on Miscarriage and remains completed. Sponsored by HAWLER Maternity Hospital, it has been updated 5 times since 2008, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Jan 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

HAWLER Maternity Hospital
Hawler Medical University

Data source: Hawler Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Erbil, Iraq